MONTVALE, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. announced today that it will report its Third quarter 2006 financial results on Thursday, November 9, 2006, before the U.S. financial markets open. Management will provide a Company update and discuss the third quarter results during a conference call on Thursday, November 9, 2006, at 9:00 a.m. EST.
Investors and other interested parties may access the call as follows: Date: Thursday, November 9, 2006 Time: 9:00 a.m. EST Telephone (U.S.): 800.299.9086 Telephone (international): 617.786.2903 Participant Passcode: 87308676 Webcast: http://www.memorypharma.com under the “Investors” section
An audio replay of the conference call will be available from 11:00 a.m. EST on Thursday, November 9, 2006, until Thursday, November 16, 2006. To access the replay, please dial 888.286.8010 (U.S.) or 617.801.6888 (international) and enter pass code number 44660408. An audio replay of the conference call will also be available under the “Investors” section of the Company’s website during the same period.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer’s disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at http://www.memorypharma.com.
Memory Pharmaceuticals Corp.
CONTACT: Jzaneen Lalani of Memory Pharmaceuticals Corp., Vice President,Legal Affairs, +1-201-802-7249, or Laura Perry of Stern Investor Relations,Inc., +1-212-362-1200
Web site: http://www.memorypharma.com//
